Edinburgh Biosciences Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$3.01M
- Investors
-
4
Edinburgh Biosciences General Information
Description
Developer of a cataract treatment technology intended to provide an alternative to surgery with a non-invasive treatment. The company's device focuses light onto the affected lens, reducing opacity, and monitoring changes in the lens by measuring the light emitted from the protein aggregates when excited with ultraviolet rays, enabling businesses to have access to treat cataracts with light treatment and providing information on its effectiveness.
Contact Information
Website
www.edinburghbiosciences.comCorporate Office
- Unit 4B Gateway Business Park
- Beancross Road
- Grangemouth FK3 8WX
- Scotland, United Kingdom
Corporate Office
- Unit 4B Gateway Business Park
- Beancross Road
- Grangemouth FK3 8WX
- Scotland, United Kingdom
Edinburgh Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 29-Apr-2025 | $3.01M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 01-Jul-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 17-Sep-2020 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jul-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-May-2018 | $654K | Completed | Generating Revenue | ||
| 1. Grant | 01-Dec-2014 | $161K | Completed | Generating Revenue |
Edinburgh Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 332,399 | $1.306729 | $4.3 | $4.3 | 1x | $4.3 | 14.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Edinburgh Biosciences Patents
Edinburgh Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021422913-A1 | Apparatus and systems for monitoring and treating cataracts | Pending | 26-Jan-2021 | ||
| EP-4284230-A1 | Apparatus and systems for monitoring and treating cataracts | Active | 26-Jan-2021 | ||
| EP-4284230-B1 | Apparatus and systems for monitoring and treating cataracts | Active | 26-Jan-2021 | ||
| ES-3025137-T3 | Apparatus and systems for monitoring and treating cataracts | Active | 26-Jan-2021 | ||
| GB-202101007-D0 | Apparatus and systems for monitoring and treating cataracts | Active | 26-Jan-2021 | A61B3/13 |
Edinburgh Biosciences Signals
Edinburgh Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Haoguang | Venture Capital | Minority | ||
| Highland Venture Capital | Angel Group | Minority | ||
| Innovate UK | Government | |||
| UK Research and Innovation | Government |
Edinburgh Biosciences FAQs
-
When was Edinburgh Biosciences founded?
Edinburgh Biosciences was founded in 2003.
-
Where is Edinburgh Biosciences headquartered?
Edinburgh Biosciences is headquartered in Grangemouth, United Kingdom.
-
What is the size of Edinburgh Biosciences?
Edinburgh Biosciences has 10 total employees.
-
What industry is Edinburgh Biosciences in?
Edinburgh Biosciences’s primary industry is Other Healthcare Technology Systems.
-
Is Edinburgh Biosciences a private or public company?
Edinburgh Biosciences is a Private company.
-
What is the current valuation of Edinburgh Biosciences?
The current valuation of Edinburgh Biosciences is .
-
What is Edinburgh Biosciences’s current revenue?
The current revenue for Edinburgh Biosciences is .
-
How much funding has Edinburgh Biosciences raised over time?
Edinburgh Biosciences has raised $7.6M.
-
Who are Edinburgh Biosciences’s investors?
Haoguang, Highland Venture Capital, Innovate UK, and UK Research and Innovation have invested in Edinburgh Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process